MoneyWorks4Me

The June 2024 quarter revenue stood at Rs. 1711.37 millions, up 20.22% as compared to Rs. 1423.51 millions during the corresponding quarter last year.The Company's Net profit for the June 2024 quarter have declined marginally to Rs. 137.17  millions as against Rs. 168.60 millions reported during the corresponding quarter ended.Operating Profit saw a handsome growth to 281.96 millions from 264.63 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1711.37 1423.51 20.22 1711.37 1423.51 20.22 6875.83 6167.34 11.49
Other Income 18.97 11.02 72.14 18.97 11.02 72.14 137.86 43.20 219.12
PBIDT 281.96 264.63 6.55 281.96 264.63 6.55 1214.53 1269.82 -4.35
Interest 43.73 5.09 759.14 43.73 5.09 759.14 58.94 24.14 144.16
PBDT 238.23 259.54 -8.21 238.23 259.54 -8.21 838.05 1245.68 -32.72
Depreciation 56.21 34.25 64.12 56.21 34.25 64.12 146.94 123.42 19.06
PBT 182.02 225.29 -19.21 182.02 225.29 -19.21 691.11 1122.26 -38.42
TAX 44.85 56.69 -20.89 44.85 56.69 -20.89 254.25 288.82 -11.97
Deferred Tax 8.67 3.31 161.93 8.67 3.31 161.93 45.12 25.05 80.12
PAT 137.17 168.60 -18.64 137.17 168.60 -18.64 436.86 833.44 -47.58
Equity 409.06 364.37 12.27 409.06 364.37 12.27 368.81 364.37 1.22
PBIDTM(%) 16.48 18.59 -11.37 16.48 18.59 -11.37 17.66 20.59 -14.21
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..